Company Overview

Company name: Green Tree Therapeutics
Description: Distributor of therapeutic vaporizers. The company’s therapeutic vaporizers offers therapeutic benefits in the delivery of beneficial CBD and THC extracts, in addition it offers alternate cannabis products, including capsules, oils, and lotions, enabling clients to avail quality cannabis products and therapeutic vaporizers.
Year founded:
Parent company:
Industry: Healthcare | Group: Healthcare Devices and Supplies | Code:
City: Vancouver
State: British Columbia
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Profitable
Ownership: Acquired/Merged
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million) 4.77
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA): 4.77
Fiscal period: TTM 3Q2018
Financing Status: The company was acquired by Abattis Bioceuticals (CNQ: ATT) for an undisclosed amount on January 24, 2018. With this acquisition, Abattis will have the opportunity to vertically integrate its supply chain from extracts right through to retail.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 2.48
Last known valuation date: 31-May-2017